Monday, January 08, 2024

Moderna - mRNA Pipeline (updated on 01/10/2024)

Moderna Announced: New England Journal of Medicine publication of pivotal phase 3 clinical safety and efficacy data for MRNA-1345, the company's investigational respiratory syncytial virus (RSV) vaccine. (News Release. Moderna. December 14, 2023)  

Moderna has multiple products at Phase 2 and Phase 3 clinical studies.

In September of 2023, Moderna announced a strategic plan with expectations to launch up to 15 new products across cancer as well as rare and infectious diseases over the next 5 years. (Moderna Scales Back COVID Vaccine Production, Pursues mRNA Medicines Plan, Biospace.com, Sep 13, 2023)

Moderna's product development progress can be summarized as below:

  • Multiple programs in development: Moderna boasts a diverse pipeline with multiple programs in various stages of development, encompassing both infectious disease vaccines and mRNA therapeutics across seven different modalities.
  • RSV vaccine expected in near future: Their respiratory syncytial virus (RSV) vaccine is nearing the finish line, with potential approval and launch in near future, marking a significant milestone.
  • Focus on multiple product launches: The company is shifting its focus to launching multiple products per year from 2025 onwards, indicating confidence in their pipeline and a potential shift towards sustained growth.
  • Leading mRNA platform: Moderna's mRNA platform remains at the forefront of the field, offering potential for rapid development and adaptation to address diverse medical needs.
  • Details of Moderna's mRNA pipeline: https://www.modernatx.com/en-US/research/product-pipeline

Overall:

Moderna's product development progress remains promising, with the RSV vaccine launch approaching and a focus on driving future product launches. However, managing the decline in COVID-19 vaccine revenue and ensuring the success of other pipeline programs will be crucial for long-term growth. Below is a summary of Moderna's mRNA pipeline - progress. The information here is for reference only, it may also carry mistakes, please check with the reference for details and accuracy.  https://www.modernatx.com/research/product-pipeline



Resources: